Variant report
Variant | nsv961774 |
---|---|
Chromosome Location | chr2:49879626-49902106 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190830551 | chr2:49882645-49882646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551084166 | chr2:49882654-49882655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs533191969 | chr2:49882684-49882685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs80336183 | chr2:49882688-49882689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75053888 | chr2:49882691-49882692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548998571 | chr2:49882697-49882698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545475439 | chr2:49882754-49882755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537758985 | chr2:49882762-49882763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534764029 | chr2:49882768-49882769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569295084 | chr2:49882781-49882782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529240923 | chr2:49882808-49882809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374421202 | chr2:49882821-49882822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs17794773 | chr2:49882863-49882864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573464374 | chr2:49882866-49882867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540867732 | chr2:49882868-49882869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555686606 | chr2:49882937-49882938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574237017 | chr2:49882949-49882950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544596728 | chr2:49882955-49882956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562477006 | chr2:49882961-49882962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532793895 | chr2:49882969-49882970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562607305 | chr2:49882982-49882983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140734640 | chr2:49883005-49883006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs144093496 | chr2:49883018-49883019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs559857604 | chr2:49883036-49883037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs527387065 | chr2:49883043-49883044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549120823 | chr2:49883101-49883102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs372990671 | chr2:49883102-49883103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs138767921 | chr2:49883154-49883155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs377573943 | chr2:49883158-49883159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551485826 | chr2:49883179-49883180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574415693 | chr2:49898816-49898817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs193174361 | chr2:49898843-49898844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183780111 | chr2:49898870-49898871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563041529 | chr2:49898910-49898911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543138098 | chr2:49898915-49898916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs533237336 | chr2:49898935-49898936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189182640 | chr2:49898973-49898974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560283567 | chr2:49899002-49899003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527993756 | chr2:49899008-49899009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140877020 | chr2:49899024-49899025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs567152018 | chr2:49899025-49899026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547068480 | chr2:49899055-49899056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191235144 | chr2:49899068-49899069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs563426824 | chr2:49899072-49899073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571351260 | chr2:49899097-49899098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538711388 | chr2:49899134-49899135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554026271 | chr2:49899135-49899136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572233229 | chr2:49899138-49899139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566855285 | chr2:49899168-49899169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs183801462 | chr2:49899189-49899190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49882600-49883000 | Enhancers | Brain Hippocampus Middle | brain |
2 | chr2:49882800-49883200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr2:49898800-49899200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr2:49899600-49900800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr2:49900800-49902800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr2:49902000-49902600 | Enhancers | HUES48 Cell Line | embryonic stem cell |